外支架减少大隐静脉桥血管术后早期失败
该研究纳入2018至2021年连续接受孤立性冠状动脉旁路移植术的357例患者、572根大隐静脉桥血管,比较外支架组与非支架组的围术期通畅率。出院时桥血管水平通畅率支架组93.8% vs 非支架组87.8%(OR 2.1,95%CI 1.0-4.5,P=0.05),患者水平无显著差异。外支架与改善围术期大隐静脉桥血管通畅率相关。
要点
- 出院时桥血管水平通畅率支架组93.8% vs 非支架组87.8%,OR 2.1(95%CI 1.0-4.5,P=0.05)。
- 患者水平通畅率支架组90.1% vs 非支架组83.5%,OR 1.8(95%CI 0.9-3.6,P=0.1),无显著差异。
- 接受2根动脉桥亚组中支架组96.5% vs 非支架组89.6%,OR 3.2(95%CI 1.2-8.4,P=0.02)。
核心结论
- 外支架与大隐静脉桥血管围术期通畅率改善相关,在桥血管水平和患者水平均有体现。
- 右冠区域的大隐静脉桥血管和高危患者使用外支架似乎具有优势。
研究设计与样本
- 研究评估2018至2021年间连续接受孤立性冠状动脉旁路移植术患者的大隐静脉桥血管通畅率。
- 共357例患者符合纳入标准,评估572根静脉桥血管;150例患者(205根大隐静脉桥血管)接受外支架,207例患者(337根大隐静脉桥血管)未接受外支架。
- 采用逻辑回归分析在患者水平和桥血管水平比较支架组与非支架组结局,协变量包括年龄、EuroSCORE II、性别、糖尿病和动脉桥血管。
- 根据不同的协变量进行亚组分析。
主要发现
- 出院时桥血管水平总体大隐静脉桥血管通畅率支架组93.8% vs 非支架组87.8%,OR 2.1(95%CI 1.0-4.5,P=0.05)。
- 出院时患者水平总体大隐静脉桥血管通畅率支架组90.1% vs 非支架组83.5%,OR 1.8(95%CI 0.9-3.6,P=0.1)。
- 接受2根动脉桥亚组中,支架组96.5% vs 非支架组89.6%,OR 3.2(95%CI 1.2-8.4,P=0.02)。
- EuroSCORE II较高(中位数>1.1)亚组中,支架组98.6% vs 非支架组88.6%,OR 8.8(95%CI 1.1-72.7,P=0.04)。
临床怎么用
- 原文结论指出外支架与改善围术期大隐静脉桥血管通畅率相关,右冠区域桥血管和高危患者似乎有使用外支架的优势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Multiple studies have shown that external stenting (ExSt) mitigates the progression of vein graft disease years after coronary artery bypass grafting (CABG). We used computed tomography to evaluate the effect of ExSt on perioperative vein graft patency. METHODS: This study assessed graft patency rates of saphenous vein grafts (SVG) in consecutive patients with isolated coronary artery bypass grafting (CABG) between 2018 and 2021. Logistic regression analyses were conducted to compare the outcomes of supported and non-supported groups at both patient and graft levels, with age, EuroSCORE II, gender, diabetes and arterial grafts as covariates. Subgroup analyses were performed based on different covariates. The goal of the study was to provide valuable insights into the clinical outcomes of SVG in patients having CABG. RESULTS: The study examined a total of 357 patients who met the inclusion criteria and evaluated 572 vein grafts. Of these, 150 patients (205 SVGs) received ExSt, whereas 207 patients (337 SVGs) did not receive ExSt. The study results indicated that the likelihood of overall SVG patency at discharge was higher in the stented group than in the non-stented group, both at the level of the grafts [93.8% vs 87.8%, odds ratio (OR) 2.1; 95% confidence interval (CI) 1.0-4.5; P = 0.05] and at the patient level (90.1% vs 83.5%, OR 1.8; 95% CI 0.9-3.6; P = 0.1). It is worth noting that the difference between the stented and non-stented groups was most significant in the subgroup that received 2 arterial grafts (96.5% vs 89.6%, OR 3.2; 95% CI 1.2-8.4; P = 0.02) and in the subgroup with a higher EuroSCORE II (median >1.1) (98.6% vs 88.6%, OR 8.8; 95% CI 1.1-72.7; P = 0.04). CONCLUSIONS: The ExSt is associated with improved perioperative SVG patency at both the graft and the patient levels. Moreover, SVGs to the right territory and high-risk patients appear to have an advantage using ExSt.
引用
- Dushaj S, Häussler A, Rings L, et al. External stenting for saphenous vein grafts reduces early postoperative graft failure. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38775662. doi:10.1093/icvts/ivae099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。